ASTERA LABS INC (1ALAB.MI) Fundamental Analysis & Valuation

BIT:1ALAB • US04626A1034

Current stock price

110 EUR
-33 (-23.08%)
Last:

This 1ALAB.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. 1ALAB.MI Profitability Analysis

1.1 Basic Checks

  • 1ALAB had positive earnings in the past year.
  • In the past year 1ALAB had a positive cash flow from operations.
1ALAB.MI Yearly Net Income VS EBIT VS OCF VS FCF1ALAB.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 0 100M -100M 200M 300M

1.2 Ratios

  • 1ALAB has a Return On Assets of 14.19%. This is in the better half of the industry: 1ALAB outperforms 76.56% of its industry peers.
  • 1ALAB has a Return On Equity (15.64%) which is comparable to the rest of the industry.
  • With a Return On Invested Capital value of 6.15%, 1ALAB perfoms like the industry average, outperforming 46.88% of the companies in the same industry.
Industry RankSector Rank
ROA 14.19%
ROE 15.64%
ROIC 6.15%
ROA(3y)-16.28%
ROA(5y)N/A
ROE(3y)-19.89%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1ALAB.MI Yearly ROA, ROE, ROIC1ALAB.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2025 0 10 -10 -20 -30

1.3 Margins

  • 1ALAB's Profit Margin of 27.50% is fine compared to the rest of the industry. 1ALAB outperforms 73.44% of its industry peers.
  • 1ALAB has a Operating Margin of 14.74%. This is comparable to the rest of the industry: 1ALAB outperforms 46.88% of its industry peers.
  • 1ALAB has a better Gross Margin (75.41%) than 95.31% of its industry peers.
Industry RankSector Rank
OM 14.74%
PM (TTM) 27.5%
GM 75.41%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
1ALAB.MI Yearly Profit, Operating, Gross Margins1ALAB.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. 1ALAB.MI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), 1ALAB is destroying value.
  • The number of shares outstanding for 1ALAB has been increased compared to 1 year ago.
  • 1ALAB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
1ALAB.MI Yearly Shares Outstanding1ALAB.MI Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 50M 100M 150M
1ALAB.MI Yearly Total Debt VS Total Assets1ALAB.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • 1ALAB has an Altman-Z score of 101.80. This indicates that 1ALAB is financially healthy and has little risk of bankruptcy at the moment.
  • 1ALAB has a better Altman-Z score (101.80) than 100.00% of its industry peers.
  • There is no outstanding debt for 1ALAB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 101.8
ROIC/WACC0.55
WACC11.18%
1ALAB.MI Yearly LT Debt VS Equity VS FCF1ALAB.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2025 0 500M 1B

2.3 Liquidity

  • A Current Ratio of 12.78 indicates that 1ALAB has no problem at all paying its short term obligations.
  • 1ALAB has a Current ratio of 12.78. This is amongst the best in the industry. 1ALAB outperforms 98.44% of its industry peers.
  • A Quick Ratio of 12.27 indicates that 1ALAB has no problem at all paying its short term obligations.
  • The Quick ratio of 1ALAB (12.27) is better than 98.44% of its industry peers.
Industry RankSector Rank
Current Ratio 12.78
Quick Ratio 12.27
1ALAB.MI Yearly Current Assets VS Current Liabilites1ALAB.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. 1ALAB.MI Growth Analysis

3.1 Past

  • 1ALAB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -269.05%.
  • The Revenue has grown by 242.24% in the past year. This is a very strong growth!
EPS 1Y (TTM)-269.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%113.04%
Revenue 1Y (TTM)242.24%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%103.89%

3.2 Future

  • 1ALAB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.05% yearly.
  • Based on estimates for the next years, 1ALAB will show a very strong growth in Revenue. The Revenue will grow by 38.28% on average per year.
EPS Next Y81.15%
EPS Next 2Y54.88%
EPS Next 3Y48.21%
EPS Next 5Y35.05%
Revenue Next Year118.37%
Revenue Next 2Y77.69%
Revenue Next 3Y62.49%
Revenue Next 5Y38.28%

3.3 Evolution

1ALAB.MI Yearly Revenue VS Estimates1ALAB.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
1ALAB.MI Yearly EPS VS Estimates1ALAB.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

2

4. 1ALAB.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 78.57, which means the current valuation is very expensive for 1ALAB.
  • Compared to the rest of the industry, the Price/Earnings ratio of 1ALAB indicates a rather expensive valuation: 1ALAB more expensive than 82.81% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of 1ALAB to the average of the S&P500 Index (27.87), we can say 1ALAB is valued expensively.
  • A Price/Forward Earnings ratio of 53.27 indicates a quite expensive valuation of 1ALAB.
  • Based on the Price/Forward Earnings ratio, 1ALAB is valued a bit more expensive than the industry average as 75.00% of the companies are valued more cheaply.
  • 1ALAB's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 38.51.
Industry RankSector Rank
PE 78.57
Fwd PE 53.27
1ALAB.MI Price Earnings VS Forward Price Earnings1ALAB.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1ALAB indicates a rather expensive valuation: 1ALAB more expensive than 93.75% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, 1ALAB is valued a bit more expensive than the industry average as 60.94% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 94.08
EV/EBITDA 174.4
1ALAB.MI Per share data1ALAB.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as 1ALAB's earnings are expected to grow with 48.21% in the coming years.
PEG (NY)0.97
PEG (5Y)N/A
EPS Next 2Y54.88%
EPS Next 3Y48.21%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. 1ALAB.MI Dividend Analysis

5.1 Amount

  • 1ALAB does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

1ALAB.MI Fundamentals: All Metrics, Ratios and Statistics

ASTERA LABS INC

BIT:1ALAB (2/24/2026, 7:00:00 PM)

110

-33 (-23.08%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-10
Earnings (Next)05-04
Inst Owners79.38%
Inst Owner ChangeN/A
Ins Owners10.44%
Ins Owner ChangeN/A
Market Cap18.72B
Revenue(TTM)723.04M
Net Income(TTM)198.87M
Analysts80.71
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)28.26%
Min EPS beat(2)23.34%
Max EPS beat(2)33.19%
EPS beat(4)4
Avg EPS beat(4)27.63%
Min EPS beat(4)13.95%
Max EPS beat(4)40.06%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)9.25%
Min Revenue beat(2)9.05%
Max Revenue beat(2)9.44%
Revenue beat(4)4
Avg Revenue beat(4)7.16%
Min Revenue beat(4)2.08%
Max Revenue beat(4)9.44%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)0.07%
EPS NQ rev (3m)N/A
EPS NY rev (1m)1.57%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0.05%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 78.57
Fwd PE 53.27
P/S 29.85
P/FCF 94.08
P/OCF 81.84
P/B 16.97
P/tB 16.97
EV/EBITDA 174.4
EPS(TTM)1.4
EY1.27%
EPS(NY)2.06
Fwd EY1.88%
FCF(TTM)1.17
FCFY1.06%
OCF(TTM)1.34
OCFY1.22%
SpS3.68
BVpS6.48
TBVpS6.48
PEG (NY)0.97
PEG (5Y)N/A
Graham Number14.288 (-87.01%)
Profitability
Industry RankSector Rank
ROA 14.19%
ROE 15.64%
ROCE 8.2%
ROIC 6.15%
ROICexc 48.23%
ROICexgc 48.23%
OM 14.74%
PM (TTM) 27.5%
GM 75.41%
FCFM 31.73%
ROA(3y)-16.28%
ROA(5y)N/A
ROE(3y)-19.89%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 692.01%
Cap/Sales 4.74%
Interest Coverage 250
Cash Conversion 236.4%
Profit Quality 115.38%
Current Ratio 12.78
Quick Ratio 12.27
Altman-Z 101.8
F-Score8
WACC11.18%
ROIC/WACC0.55
Cap/Depr(3y)573.57%
Cap/Depr(5y)N/A
Cap/Sales(3y)5.29%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-269.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%113.04%
EPS Next Y81.15%
EPS Next 2Y54.88%
EPS Next 3Y48.21%
EPS Next 5Y35.05%
Revenue 1Y (TTM)242.24%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%103.89%
Revenue Next Year118.37%
Revenue Next 2Y77.69%
Revenue Next 3Y62.49%
Revenue Next 5Y38.28%
EBIT growth 1Y-293.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year240.9%
EBIT Next 3Y91.65%
EBIT Next 5Y56.74%
FCF growth 1Y761.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1174.83%
OCF growth 3YN/A
OCF growth 5YN/A

ASTERA LABS INC / 1ALAB.MI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ASTERA LABS INC?

ChartMill assigns a fundamental rating of 4 / 10 to 1ALAB.MI.


What is the valuation status of ASTERA LABS INC (1ALAB.MI) stock?

ChartMill assigns a valuation rating of 2 / 10 to ASTERA LABS INC (1ALAB.MI). This can be considered as Overvalued.


What is the profitability of 1ALAB stock?

ASTERA LABS INC (1ALAB.MI) has a profitability rating of 3 / 10.


Can you provide the PE and PB ratios for 1ALAB stock?

The Price/Earnings (PE) ratio for ASTERA LABS INC (1ALAB.MI) is 78.57 and the Price/Book (PB) ratio is 16.97.


How financially healthy is ASTERA LABS INC?

The financial health rating of ASTERA LABS INC (1ALAB.MI) is 8 / 10.